RK Capital Management LLC trimmed its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 34.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 92,020 shares of the specialty pharmaceutical company’s stock after selling 48,875 shares during the period. […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […]
Jazz Pharmaceuticals (NASDAQ:JAZZ) Downgraded to Buy at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average twelve-month target […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price boosted by stock analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective suggests a potential […]